Analyst Ratings for Merck (MRK)
MRK Rating Summary
MRK Price Target Summary
- Highest: $56.00 (Jefferies)
- Lowest: $40.00 (Barclays)
- Average: $47.30
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$47.30 (-0.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/28/2013 | Jefferies » Updated 6/7/2013 |
Upgrade | Buy (Hold) |
56.00 (54.00) |
47.16 | 47.75 | 1.25% | Details |
| 3/4/2013 | BofA/Merrill Lynch | Upgrade | Buy (Neutral) |
N/A (N/A) |
42.63 | 47.75 | 12.01% | Details |
| 2/4/2013 | Morgan Stanley | Downgrade | Underweight (Equalweight) |
N/A (N/A) |
41.83 | 47.75 | 14.15% | Details |
| 2/4/2013 | Leerink Swann » Updated 5/20/2013 |
Downgrade | Market Perform (Outperform) |
N/A (N/A) |
41.83 | 47.75 | 14.15% | Details |
| 11/30/2012 | Citi | New Coverage | Neutral (N/A) |
44.00 (N/A) |
44.71 | 47.75 | 6.8% | Details |
| 11/20/2012 | MKM Partners | Upgrade | Buy (Neutral) |
51.00 (N/A) |
43.34 | 47.75 | 10.18% | Details |
| 11/12/2012 | BMO Capital | Upgrade | Outperform (Market Perform) |
50.00 (50.00) |
44.05 | 47.75 | 8.4% | Details |
| 4/26/2012 | Auriga | New Coverage | Buy (N/A) |
47.00 (N/A) |
38.43 | 47.75 | 24.25% | Details |
| 2/3/2012 | Davenport | Downgrade | Neutral (N/A) |
40.00 (N/A) |
38.44 | 47.75 | 24.22% | Details |
| 1/24/2012 | ISI Group | New Coverage | Buy (N/A) |
45.00 (N/A) |
38.77 | 47.75 | 23.16% | Details |
| 4/29/2011 | Hapoalim Securities | Upgrade | Buy (N/A) |
N/A (N/A) |
35.98 | 47.75 | 32.71% | Details |
| 2/7/2011 | Cowen | Downgrade | Neutral (N/A) |
N/A (N/A) |
32.89 | 47.75 | 45.18% | Details |
| 1/19/2011 | Wells Fargo » Updated 4/30/2013 |
New Coverage | Outperform (N/A) |
N/A (N/A) |
33.87 | 47.75 | 40.98% | Details |
| 11/30/2010 | Credit Agricole | New Coverage | Buy (N/A) |
N/A (N/A) |
34.79 | 47.75 | 37.25% | Details |
